Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -111,158 | -60,825 | -218,960 | -198,806 | -139,706 |
| Depreciation Amortization | 2,196 | 1,129 | 6,422 | 5,086 | 3,330 |
| Income taxes - deferred | 85 | -241 | -850 | -1,693 | -1,647 |
| Accounts payable and accrued liabilities | -3,897 | -3,838 | -6,871 | -3,990 | 1,080 |
| Other Working Capital | -21,687 | -14,029 | -80,348 | -66,134 | -42,408 |
| Other Operating Activity | 18,930 | 11,879 | 50,932 | 35,208 | 20,195 |
| Operating Cash Flow | $-115,531 | $-65,925 | $-249,675 | $-230,329 | $-159,156 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -978 | -713 | -2,350 | -1,776 | -1,102 |
| Investing Cash Flow | $-978 | $-713 | $-2,350 | $-1,776 | $-1,102 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13 | 12 | 37 | 4 | 3 |
| Other Financing Activity | -117 | -66 | -168 | -120 | -89 |
| Financing Cash Flow | $-104 | $-54 | $-131 | $-116 | $-86 |
| Exchange Rate Effect | -1,993 | -1,944 | 804 | 1,026 | 2,275 |
| Beginning Cash Position | 628,715 | 628,715 | 880,067 | 880,067 | 880,067 |
| End Cash Position | 510,109 | 560,079 | 628,715 | 648,872 | 721,998 |
| Net Cash Flow | $-118,606 | $-68,636 | $-251,352 | $-231,195 | $-158,069 |
| Free Cash Flow | |||||
| Operating Cash Flow | -115,531 | -65,925 | -249,675 | -230,329 | -159,156 |
| Capital Expenditure | -978 | -713 | -2,350 | -1,776 | -1,102 |
| Free Cash Flow | -116,509 | -66,638 | -252,025 | -232,105 | -160,258 |